Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation

BACKGROUND: Epigenetic reprogramming reportedly has a crucial role in prostate cancer (PCa) progression. RNA modification is a hot topic in epigenetics, and N6-methyladenosine (m6A) accounts for approximately 60% of RNA chemical modifications. The aim of this study was to evaluate the m6A modificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Yongjun, Zhang, Xiaodong, Ping, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772220/
https://www.ncbi.nlm.nih.gov/pubmed/35045837
http://dx.doi.org/10.1186/s12935-021-02438-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772220/
https://www.ncbi.nlm.nih.gov/pubmed/35045837
http://dx.doi.org/10.1186/s12935-021-02438-1

Ejemplares similares